Research has found that targeting VPS4 can trigger an anti-tumor immune response, driven by STING, which helps to suppress the growth of rhabdomyosarcoma. This approach may offer a potential way to combat this type of cancer. The findings suggest a possible therapeutic strategy for rhabdomyosarcoma treatment.